Showing results (641-650 of 673) with videos related to
Sort By:
Pageof 68
HIV Clinical Trials|December 20, 2011
Examination of noninferiority, safety, and tolerability of lopinavir/ritonavir and raltegravir compared with lopinavir/ritonavir and tenofovir/ emtricitabine in antiretroviral-naïve subjects: the progress study, 48-week resultsJacques Reynes, Adebayo Lawal, Federico Pulido, et al.HIV Clinical Trials|April 19, 2012
Impact of baseline virologic, immunologic, and demographic characteristics on virologic responses in the Gemini studyAnchalee Avihingsanon, Kiat Ruxrungtham, Harold Katner, et al.HIV Clinical Trials|June 21, 2011
Use of non-nucleoside analogues together with rifampin in HIV patients with tuberculosisJ Villar, P Sánchez, A González, et al.HIV Clinical Trials|November 3, 2011
Assessment of vascular function in HIV-infected patientsJuliana P Borges, Eduardo Tibiriçá, Pedro Paulo S Soares, et al.HIV Clinical Trials|November 3, 2011
Body mass index and CD4+ T-lymphocyte recovery in HIV-infected men with viral suppression on antiretroviral therapyBrandon Palermo, Ronald J Bosch, Kara Bennett, et al.HIV Clinical Trials|April 9, 2014
Switching to an etravirine-containing regimen due to drug intolerance in clinical practiceL Martín-Carbonero, V Moreno, G Ramírez-Olivenza, et al.HIV Clinical Trials|April 9, 2014
Failure to identify HIV-infected individuals in a clinical trial using a single HIV rapid test for screeningEstelle Piwowar-Manning, Jessica M Fogel, Oliver Laeyendecker, et al.HIV Clinical Trials|August 9, 2013
Flow cytometry analysis with a new FITC-conjugated monoclonal antibody-3E12 for HLA-B*57:01 rapid screening in prevention of abacavir hypersensitivity in HIV-1-infected patientsC Rodríguez-Sáinz, L Valor, D C Hernández, et al.HIV Clinical Trials|August 9, 2013
Immune response after a single dose of the 2010/11 trivalent, seasonal influenza vaccine in HIV-1-infected patients and healthy controlsMarkus Bickel, Christin Lassmann, Imke Wieters, et al.HIV Clinical Trials|January 8, 2016
Improvement of lipid profiles when switching from efavirenz to rilpivirine in HIV-infected patients with dyslipidemiaPornpimol Thamrongwonglert, Ploenchan Chetchotisakd, Siriluck Anunnatsiri, et al.Pageof 68